Walgreens Boots Alliance (WBA)
(Delayed Data from NSDQ)
$8.74 USD
+0.09 (1.04%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $8.75 +0.01 (0.11%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.74 USD
+0.09 (1.04%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $8.75 +0.01 (0.11%) 7:58 PM ET
5-Strong Sell of 5 5
D Value D Growth A Momentum C VGM
Zacks News
Markets Flattish Ahead of CPI, Jobless Claims, Q3 Earnings
by Mark Vickery
Thursday's CPI report is arguably the single-most important data point ahead of the next Fed meeting.
Company News for Oct 12, 2022
by Zacks Equity Research
Companies In The News Are: AAL, CS, WBA, UBER.
Walgreens Earnings Preview: Can WBA Stock Rebound?
by Shaun Pruitt
WBA's upcoming earnings release on Thursday, October 13 will be closely monitored as many businesses struggle amid rising inflation and tougher operating environments. Investors will want to see some upbeat guidance more than anything else.
Wall Street Waits for Q3 2022 Earnings to Kick Off
by Zacks Equity Research
Wall Street Waits for Q3 2022 Earnings to Kick Off.
Walgreens (WBA) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Walgreens (WBA) is expected to have registered growth in Q4 in its U.S. retail pharmacy business, banking on demand for vaccinations and tests amid the ongoing series of contagious virus spread.
Big Week for Data, Earnings Starts Quiet
by Mark Vickery
The big news for the week will be along two paths: CPI data for September and the start of Q3 earnings season.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $33.16 in the latest trading session, marking a -0.69% move from the prior day.
Rite Aid (RAD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of -36.96% and 0.66%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $32.43, moving -0.8% from the previous trading session.
Walgreens Boots' (WBA) Product Expansion Aids Amid Rivalry
by Zacks Equity Research
Sales contributions from Walgreens Boots' (WBA) newly-formed Walgreens Health segment instill investors' optimism.
Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXG
Walgreens Boots Alliance (WBA) Stock Moves -1.65%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $33.43, moving -1.65% from the previous trading session.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $34.23, moving -1.55% from the previous trading session.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $36.24 in the latest trading session, marking a +0.78% move from the prior day.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $35.32, marking a +0.14% move from the previous day.
Walgreens Boots Alliance, Inc. (WBA) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Walgreens Boots Alliance (WBA) Stock Moves -0.34%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $35.06 in the latest trading session, marking a -0.34% move from the prior day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $36.80, moving +0.08% from the previous trading session.
Walgreens Boots Alliance, Inc. (WBA) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Walgreens Boots Alliance (WBA) Stock Moves -0.05%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $38.22, marking a -0.05% move from the previous day.
Investors Heavily Search Walgreens Boots Alliance, Inc. (WBA): Here is What You Need to Know
by Zacks Equity Research
Walgreens (WBA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here is What to Know Beyond Why Walgreens Boots Alliance, Inc. (WBA) is a Trending Stock
by Zacks Equity Research
Walgreens (WBA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
NCR Stock Rallies 13% on Veritas Capital Takeover Report
by Zacks Equity Research
If Veritas Capital succeeds in concluding a takeover deal for NCR, it is likely to be one of the biggest leveraged buyouts in recent history.
Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance and Amazon
by Zacks Equity Research
CVS Health, Walgreens Boots Alliance and Amazon have been highlighted in this Industry Outlook article.